SAGE-718

The future of SAGE-718 in Alzheimer’s disease treatment 1:52
The future of SAGE-718 in Alzheimer’s disease treatment
Aaron Koenig • 28 Nov 2022
Insights into the upcoming LIGHTWAVE trial using SAGE-718 to treat patients with MCI and early AD 1:42
Insights into the upcoming LIGHTWAVE trial using SAGE-718 to treat patients with MCI and early AD
Aaron Koenig • 28 Nov 2022
New mechanisms to treat Alzheimer’s disease by targeting the NMDA pathway 1:00
New mechanisms to treat Alzheimer’s disease by targeting the NMDA pathway
Aaron Koenig • 28 Nov 2022
Phase II clinical trial of SAGE-718 for the treatment of MCI and early AD 2:05
Phase II clinical trial of SAGE-718 for the treatment of MCI and early AD
Aaron Koenig • 28 Nov 2022
The content of VJDementia is intended for healthcare professionals